Investigation on Acute Dose-Dependent Effects of Anthocyanins on Endothelial Function
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Endothelial function
研究概览
简要总结
Anthocyanins are a subclass of (poly)phenols very abundant in berries and red grapes. Increasing evidence from human epidemiological and dietary intervention studies suggests that anthocyanins may have cardiovascular health benefits. The present study aimes to investigate whether pure anthocyanin consumption improves endothelial function in healthy individuals and if these effects are dose-dependent.
详细描述
Anthocyanins are a subclass of (poly)phenols very abundant in berries and red grapes. Increasing evidence from human epidemiological and dietary intervention studies suggests that anthocyanins may have cardiovascular health benefits. A double blind randomized controlled crossover, dose-response study will be conducted in 10 young healthy men. On 6 different days, subjects will consume capsules containing 0, 80, 160, 240, 320 and 480 mg of purified anthocyanins with a one-week wash-out period. Flow-mediated dilation (FMD) and blood pressure will be measured at baseline and at 2 and 6 h after consumption. Blood samples will also be taken and quantification of plasma anthocyanin metabolites using UPLC-Q-TOF-MS will be performed. The aim is to investigate whether purified anthocyanins are able to increase FMD at 2h and 6h post consumption and whether these effects correlate with anthocyanin- derived phenolic acids quantified in the plasma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy men aged 18-45 years old
- •Subjects are willing to maintain their normal eating/drinking habits and exercise habits to avoid changes in body weight over the duration of the study - subjects are able to understand the nature of the study
- •able to give signed written informed consent
- •signed written infomred consent form
- •healthy male subjects (no clinical signs or symptoms of CVD.
排除标准
- •cardiovascular disease, acute inflammation, cardiac arrhythmia, renal failure, heart failure (NYHA II-IV), diabetes mellitus, C-reactive protein > 0.5 mg/dL, malignant disease, hypotension (≤100 / 60 mm Hg)
研究组 & 干预措施
Placebo
Capsules containing maltodextrin
干预措施: anthocyanins (Dietary Supplement)
80 mg ACN
Capsules containing 80 mg anthocyanins
干预措施: anthocyanins (Dietary Supplement)
160 mg ACN
Capsules containing 160 mg anthocyanins
干预措施: anthocyanins (Dietary Supplement)
240 mg ACN
Capsules containing 240 mg anthocyanins
干预措施: anthocyanins (Dietary Supplement)
320 mg ACN
Capsules containing 320 mg anthocyanins
干预措施: anthocyanins (Dietary Supplement)
480 mg ACN
Capsules containing 480 mg anthocyanins
干预措施: anthocyanins (Dietary Supplement)
结局指标
主要结局
Endothelial function
时间窗: Changes from baseline to 2 hours postconsumption
Flow-mediated dilation
次要结局
- Blood pressure(0 and 2 hours postconsumption)
研究者
Klinik für Kardiologie, Pneumologie und Angiologie
Principal Investigator
Heinrich-Heine University, Duesseldorf
